Exact Mass: 519.3770978

1-linoleoyl-GPC (18:2)

(2-{[(2R)-2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

LysoPC(0:0/18:2(9Z,12Z))

(2-{[(2R)-3-hydroxy-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

LysoPC(0:0/18:2(9Z,12Z)) is a lysophosphatidylcholine, which is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2 as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. There is also a phospholipase A1, which is able to cleave the sn-1 ester bond. Lysophosphatidylcholine has pro-inflammatory properties in vitro and it is known to be a pathological component of oxidized lipoproteins (LDL) in plasma and of atherosclerotic lesions. Recently, it has been found to have some functions in cell signalling, and specific receptors (coupled to G proteins) have been identified. It activates the specific phospholipase C that releases diacylglycerols and inositol triphosphate with resultant increases in intracellular Ca2+ and activation of protein kinase C. It also activates the mitogen-activated protein kinase in certain cell types. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPC(0:0/18:2(9Z,12Z)), in particular, consists of one chain of linoleic acid at the C-2 position.

Boceprevir

3-{2-[N-tert-butyl-(C-hydroxycarbonimidoyl)amino]-3,3-dimethylbutanoyl}-N-(1-carbamoyl-3-cyclobutyl-1-oxopropan-2-yl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboximidate

LPC 18:2

1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

Annotation level-3

LysoPC(18:2/0:0)

(2-{[(2R)-2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

1-Linoleoylglycerophosphocholine

2-[hydroxy-[2-hydroxy-3-[(9Z,12Z)-octadeca-9, 12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

Phe Ile Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylpentanamido]hexanoic acid

Phe Ile Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]hexanamido]-3-methylpentanoic acid

Phe Ile Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]hexanamido]-4-methylpentanoic acid

Phe Ile Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-4-methylpentanamido]hexanoic acid

Phe Lys Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-methylpentanamido]-3-methylpentanoic acid

Phe Lys Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-methylpentanamido]-4-methylpentanoic acid

Phe Lys Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-4-methylpentanamido]-3-methylpentanoic acid

Phe Lys Leu Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-4-methylpentanamido]-4-methylpentanoic acid

Phe Leu Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanamido]hexanoic acid

Phe Leu Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]hexanamido]-3-methylpentanoic acid

Phe Leu Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]hexanamido]-4-methylpentanoic acid

Phe Leu Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanamido]hexanoic acid

Ile Phe Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylpentanamido]hexanoic acid

Ile Phe Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]hexanamido]-3-methylpentanoic acid

Ile Phe Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]hexanamido]-4-methylpentanoic acid

Ile Phe Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-4-methylpentanamido]hexanoic acid

Ile Ile Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-phenylpropanamido]hexanoic acid

Ile Ile Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]hexanamido]-3-phenylpropanoic acid

Ile Lys Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-phenylpropanamido]-3-methylpentanoic acid

Ile Lys Phe Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-phenylpropanamido]-4-methylpentanoic acid

Ile Lys Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-methylpentanamido]-3-phenylpropanoic acid

Ile Lys Leu Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-methylpentanamido]-3-phenylpropanoic acid

Ile Leu Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-phenylpropanamido]hexanoic acid

Ile Leu Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]hexanamido]-3-phenylpropanoic acid

Lys Phe Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylpentanoic acid

Lys Phe Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-methylpentanamido]-4-methylpentanoic acid

Lys Phe Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylpentanoic acid

Lys Phe Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanoic acid

Lys Ile Phe Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylpentanoic acid

Lys Ile Phe Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-phenylpropanamido]-4-methylpentanoic acid

Lys Ile Ile Phe

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-methylpentanamido]-3-phenylpropanoic acid

Lys Ile Leu Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-4-methylpentanamido]-3-phenylpropanoic acid

Lys Leu Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylpentanoic acid

Lys Leu Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-phenylpropanamido]-4-methylpentanoic acid

Lys Leu Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-methylpentanamido]-3-phenylpropanoic acid

Lys Leu Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-4-methylpentanamido]-3-phenylpropanoic acid

Leu Phe Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylpentanamido]hexanoic acid

Leu Phe Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]hexanamido]-3-methylpentanoic acid

Leu Phe Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]hexanamido]-4-methylpentanoic acid

Leu Phe Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-4-methylpentanamido]hexanoic acid

Leu Ile Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-phenylpropanamido]hexanoic acid

Leu Ile Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]hexanamido]-3-phenylpropanoic acid

Leu Lys Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-phenylpropanamido]-3-methylpentanoic acid

Leu Lys Phe Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-phenylpropanamido]-4-methylpentanoic acid

Leu Lys Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-methylpentanamido]-3-phenylpropanoic acid

Leu Lys Leu Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-methylpentanamido]-3-phenylpropanoic acid

Leu Leu Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-phenylpropanamido]hexanoic acid

Leu Leu Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]hexanamido]-3-phenylpropanoic acid

PC(18:2/0:0)

3,5,9-Trioxa-4-phosphaheptacosa-11,13-dien-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

18:2 LYSO-PC

3,5,9-Trioxa-4-phosphaheptacosa-18,21-dien-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, [R-(Z,Z)]-

Linoleoyllysolecithin

1-mono-, 3-(dihydrogen phosphate), monoester with choline hydroxide, inner salt

PC(P-19:1/0:0)

1-(1Z,12Z-nonadecadienyl)-sn-glycero-3-phosphocholine

LPC O-19:2

1-(1Z,12Z-nonadecadienyl)-sn-glycero-3-phosphocholine

Poly(1,2-dihydro-2,2,4-trimethylquinoline)

C36H45N3 (519.361329)

Boc-d-dap(z)-oh dcha

C28H45N3O6 (519.330819)

BOCEPREVIR

C27H23N5O4.1/2H2O (519.342052)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent COVID info from Guide to PHARMACOLOGY Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

N-Boc-N-Cbz-L-2,3-diaminopropionic acid dicyclohexylamine salt

C28H45N3O6 (519.330819)

Compound 48/80

C32H45N3O3 (519.346074)

Pranlukast hemihydrate

1-linoleoyl-GPC (18:2)

(2-{[(2R)-2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

LysoPC(18:2(9Z,12Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:2(9Z,12Z)), in particular, consists of one chain of linoleic acid at the C-1 position. The linoleic acid moiety is derived from seed oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. Lysopc(18:2(9z,12z)), also known as lysophosphatidylcholine(18:2/0:0) or lpc(18:2n6/0:0), is a member of the class of compounds known as 1-acyl-sn-glycero-3-phosphocholines. 1-acyl-sn-glycero-3-phosphocholines are glycerophosphocholines in which the glycerol is esterified with a fatty acid at O-1 position, and linked at position 3 to a phosphocholine. Thus, lysopc(18:2(9z,12z)) is considered to be a glycerophosphocholine lipid molecule. Lysopc(18:2(9z,12z)) is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Lysopc(18:2(9z,12z)) can be found in a number of food items such as japanese persimmon, jicama, rubus (blackberry, raspberry), and chinese bayberry, which makes lysopc(18:2(9z,12z)) a potential biomarker for the consumption of these food products. Lysopc(18:2(9z,12z)) can be found primarily in blood, feces, and urine, as well as throughout all human tissues. Moreover, lysopc(18:2(9z,12z)) is found to be associated with schizophrenia.

(2-Hydroxy-3-octadeca-9,12-dienoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

4-(dimethylamino)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide

4-(dimethylamino)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide

4-(dimethylamino)-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide

[2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

Ldgts 20:5

HexCer 18:0;2O/3:0

HexCer 16:0;2O/5:0

HexCer 12:0;2O/9:0

HexCer 19:0;2O/2:0

HexCer 9:0;2O/12:0

HexCer 8:0;2O/13:0

HexCer 13:0;2O/8:0

HexCer 15:0;2O/6:0

HexCer 14:0;2O/7:0

HexCer 17:0;2O/4:0

NAGly 11:0/18:3

NAGly 16:3/13:0

NAGly 18:3/11:0

NAGly 13:1/16:2

NAGly 13:0/16:3

NAGly 16:2/13:1

[2-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

2-aminoethyl [3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-hydroxypropyl] hydrogen phosphate

HexCer 11:0;2O/10:0

HexCer 10:0;2O/11:0

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (11Z,14Z)-henicosa-11,14-dienoate

(E)-3-hydroxy-2-(2-hydroxytridecanoylamino)tetradec-4-ene-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]tridecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]dodecane-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)dodec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxydodecanoylamino)pentadec-4-ene-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]undecane-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)tridec-4-ene-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]pentadecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]tetradecane-1-sulfonic acid

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] acetate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] butanoate

(E)-3-hydroxy-2-(2-hydroxyheptadecanoylamino)dec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(2-hydroxyhexadecanoylamino)undec-4-ene-1-sulfonic acid

2-(Hexadecanoylamino)-3-hydroxydodecane-1-sulfonic acid

3-Hydroxy-2-(undecanoylamino)heptadecane-1-sulfonic acid

3-Hydroxy-2-(octadecanoylamino)decane-1-sulfonic acid

3-Hydroxy-2-(tetradecanoylamino)tetradecane-1-sulfonic acid

3-Hydroxy-2-(pentadecanoylamino)tridecane-1-sulfonic acid

2-(Decanoylamino)-3-hydroxyoctadecane-1-sulfonic acid

2-(Heptadecanoylamino)-3-hydroxyundecane-1-sulfonic acid

3-Hydroxy-2-(tridecanoylamino)pentadecane-1-sulfonic acid

2-(Dodecanoylamino)-3-hydroxyhexadecane-1-sulfonic acid

[2-acetyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

N-(decanoyl)-4E-heptadecasphingenine-1-phosphate

N-(dodecanoyl)-4E-pentadecasphingenine-1-phosphate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] pentanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] propanoate

[2-hydroxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-hydroxy-2-[(9Z,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

lysoDGTS 20:5

[(2R)-2-hydroxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hydroxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hydroxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(nonanoylamino)dodeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(octanoylamino)trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(butanoylamino)-3-hydroxyheptadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(heptanoylamino)-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-(hexanoylamino)-3-hydroxypentadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(pentanoylamino)hexadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E)-2-acetamido-3-hydroxynonadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)octadeca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium

1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

A lysophosphatidylcholine 18:2 in which the acyl group at position 1 is (9Z,12Z)-octadecadienoyl.

2-linoleoyl-sn-glycero-3-phosphocholine

A lysophosphatidylcholine 18:2 in which the acyl group is specified as linoleoyl and is located at position 2.

1-(2E,4E-octadecadienoyl)-sn-glycero-3-phosphocholine

1-(1Z,12Z-nonadecadienyl)-sn-glycero-3-phosphocholine

linoleoyl-sn-glycero-3-phosphocholine

A lysophosphatidylcholine in which the acyl group (position not specified) is linoleoyl.

lysophosphatidylcholine(0:0/18:2)

A 2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group contains 18 carbons and 2 double bonds.

Lysophosphatidylcholine(18:2/0:0)

A 1-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group contains 18 carbons and 2 double bonds.

lysophosphatidylcholine (18:2/0:0)

A lysophosphatidylcholine 18:2 in which the acyl group is located at position 1.

Lysophosphatidylcholine 18:2

A lysophosphatidylcholine in which the acyl group (position not specified) contains 18 carbons and 2 double bonds.

1-Linoleoyl-sn-glycero-3-phosphocholine

A lysophosphatidylcholine 18:2 in which the acyl group at position 1 is (9Z,12Z)-octadecadienoyl.

PE(21:2)

PE(10:0(1)_11:2)

PC(18:2)

PC(8:0(1)_10:2)

NA-DOPA 22:0

MGTS 20:5

LPC 0:0/18:2

LPC 18:2/0:0

LPC 18:2(9Z,12Z)

PC O-14:1/4:1

PC O-16:2/2:0

PC O-18:2

PC O-8:1/10:1

PC P-14:0/4:1

PC P-14:0/4:1 or PC O-14:1/4:1

PC P-16:1/2:0

PC P-16:1/2:0 or PC O-16:2/2:0

PC P-18:1

PC P-18:1 or PC O-18:2

LPE O-22:2

LPE P-22:1

LPE P-22:1 or LPE O-22:2

CerP 14:1;O2/13:0

CerP 14:2;O2/12:0;O

CerP 15:1;O2/12:0

CerP 15:2;O2/11:0;O

CerP 16:1;O2/11:0

CerP 16:2;O2/10:0;O

CerP 17:1;O2/10:0

CerP 26:2;O2;O

CerP 27:1;O2

ST 28:2;O4;Gly

ST 29:1;O3;Gly

ST 22:1;O;HexNAc

(1s,12s,15s,20r)-7-[(s)-(3,3-dimethyloxiran-2-yl)(hydroxy)methyl]-15-hydroxy-1,16,16,20-tetramethyl-8-(3-methylbut-2-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-one

(1s,12s,15s,20r)-7-[(s)-(3,3-dimethyloxiran-2-yl)(hydroxy)methyl]-15-hydroxy-1,16,16,20-tetramethyl-8-(3-methylbut-2-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-one

C33H45NO4 (519.334841)

(2-{[(2r)-2-hydroxy-3-[(9z,12z)-octadeca-9,12-dienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium